Microport Scientific

Microport Scientific EBITDA TCAC 3A

CAGR de l'EBITDA (3 ans) de Microport Scientific (853.HK) au 24 oct. 2026.

EBITDA TCAC 3A

-

Dernière mise à jour:

CAGR de l'EBITDA (3 ans) de Microport Scientific est 2026 - . CAGR de l'EBITDA (3 ans) de Microport Scientific était 2025 - . Elle diminue ainsi de % plus faible par rapport à l'année précédente.

Accéder à ces données via l’API Eulerpool

100 000 requêtes/mois gratuites · sans carte bancaire

Microport Scientific Analyse d'actions

Que fait Microport Scientific ? Microport Scientific Corp is a leading company in the field of medical device manufacturing based in Shanghai, China. The company was founded in 1998 and has since experienced strong growth. The origins of Microport Scientific Corp are in China, where the company manufactures medical devices such as orthopedic products, stent-like implants for the treatment of cardiovascular diseases, and cardiac rhythm management devices. Today, the company is also active international and present in more than 70 countries. The business strategy of Microport Scientific Corp is focused on the development and offering of high-quality, innovative medical technologies. The company pursues a multidisciplinary research and development strategy with the aim of developing a wide range of medical devices and instruments. The products of Microport Scientific Corp are used in numerous specialized areas of the healthcare industry, such as cardiology, orthopedics, and minimally invasive surgery. The company operates in two main business segments - the medical technology division and the pharmaceutical division. The medical technology division of Microport Scientific Corp manufactures a wide range of medical devices, including artificial joints, pacemakers and defibrillators, cardiac catheters and balloon catheters, wires and guiding catheters for minimally invasive procedures, and other products. The company places great emphasis on utilizing the latest technology in each product line to ensure high quality and efficiency in every product. The pharmaceutical division of Microport Scientific Corp has focused on the development of pharmaceuticals. The company is working on developing and commercializing new pharmaceutical technologies to contribute to the health of people worldwide. Microport Scientific Corp's focus in the pharmaceutical sector lies in the manufacturing of medications for the treatment of cancer, cardiovascular diseases, and neurological diseases. In recent times, Microport Scientific Corp has also ventured into the field of intelligent healthcare solutions. The intelligent devices and applications developed by the company are aimed at improving healthcare for patients and increasing efficiency for doctors and nursing staff. An example of a product from Microport Scientific Corp is the Magmaris Magnesium Bioresorbable Stent for the treatment of coronary heart disease. It was designed to address the issue of long-term limitations with conventional metal titanium-coated stent implants. The bioresorbability of the stent prevents the problem of restenotic complications over an extended period. Another product from Microport Scientific Corp is the Firehawk Rapamycin-Eluting Coronary Stent for the treatment of cardiovascular diseases. The catheter made with this stent has a three-dimensional structure that ensures improved contact of the stent with the arterial wall and faster healing of the stent. Microport Scientific Corp is a company specialized in the development and manufacturing of medical devices and solutions. The company has consistently risen to the challenges in medical device technology and takes pride in offering a wide range of state-of-the-art products. With the increasing prevalence and growing importance of the healthcare industry, the products and services of Microport Scientific Corp are a valuable resource for a growing number of customers and patients. Microport Scientific est l'une des entreprises les plus populaires sur Eulerpool.

Questions fréquemment posées sur l'action Microport Scientific

Sur Eulerpool, vous trouverez l'évolution historique complète de Microport Scientific de CAGR de l'EBITDA (3 ans) depuis 2006 – avec des valeurs annuelles, des graphiques et une analyse détaillée.

Le CAGR de l'EBITDA sur 3 ans montre le taux de croissance annuel composé de l'EBITDA sur trois ans.

Pour évaluer de CAGR de l'EBITDA (3 ans), il est essentiel de le comparer avec les pairs du même secteur. Sur Eulerpool, vous pouvez trouver des comparaisons directes du secteur pour CAGR de l'EBITDA (3 ans).

de CAGR de l'EBITDA (3 ans) est un facteur clé pour les investisseurs. Les changements dans cette métrique peuvent signaler une amélioration ou une détérioration des fondamentaux, impactant directement le cours de l'action. Sur Eulerpool, vous pouvez suivre Microport Scientific de CAGR de l'EBITDA (3 ans) historiquement et en temps réel.

Accéder à ces données via l’API Eulerpool

100 000 requêtes/mois gratuites · sans carte bancaire

Croissance — Microport Scientific

Toutes les Métriques Clés — Microport Scientific

Croissance